Covid 19 Igm Igg Rapid Test Colloidal Gold - China

COVID-19 IgM/IgG Rapid Test (Colloidal Gold)

COVID-19 IgM/IgG Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of IgM and IgG antibodies to SARS-CoV-2 in human whole blood, serum, or plasma as an aid in the diagnosis of SARS-COV-2 infections.

The test kit consists of test devices and buffer.

It is for in vitro diagnostic use only, and can be used in point-of-care testing settings and central laboratories.

The novel coronaviruses belong to the β genus.

COVID-19 is an acute respiratory infectious disease.

People are generally susceptible.

Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source.

Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days.

The main manifestations include fever, fatigue and dry cough.

Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

Well Biotect COVID-19 IgM/IgG Rapid Test is an in vitro diagnostic test for the qualitative determination of COVID-19 IgM and IgG antibodies in human whole blood (finger tip), serum or plasma.

Company Contact:

• Posted By: Jiangsu Well Biotech Co., Ltd.

• Phone: 86 519 80191660

• Address: F4, C1 Building, No.9 Changyang Rd., Changzhou , Jiangsu , China

• Email:

• Website: https://www.wellbioscience.com/

• Business Description: Jiangsu Well Biotech Co., Ltd. - a Sino-American joint venture, is a professional manufacturer specialized in medical in vitro diagnostic assays and reagents, instrument research and development, and world-class sales and service, Well Biotech was established in 2006 located in No 9, Changyang Rd., Changzhou, Jiangsu China.
  
  Our flagship facility consists of an area of 1000 square meters of 100,000 level clean production workshop and 600 square meters of laboratory with registered capital of 12.85 million RMB.
  
  In addition, we have a 600-square-meter R&D center in San Diego (Silicon Valley) A full set of rapid diagnostic reagent production line and international advanced testing equipment enable us to supply consistent high quality products.
  
  Our core technologies include small molecule antigen synthesis technology, monoclonal antibody preparation technology, solid phase enzyme free technology, immunochromatography technology, test kit development and production technology, saliva sample detection and analysis technology and a number of prohibited drugs and other antigen antibody preparation and detection technology patents.
  
  Jiangsu Well Biotech Co., Ltd has established a multi-project rapid detection technology platform with saliva as the detection sample.
  
  Colloidal gold rapid diagnosis products cover five series of pregnancy, infectious disease, drugs, tumor markers and cardiac markers.
  
  Elisa kits can be used for the rapid detection of 30 prohibited drugs; The test strip has formed a full series of samples of saliva, drink and urine testing products, the annual production and sales can be over millions of pieces.